Tamer Coskun serves as a senior research advisor at Eli Lilly and Company and was instrumental in the discovery and preclinical development of GLP2
It activates the GLP-1 receptor, which signals the pancreas to release insulin, slows gastric emptying, and reduces appetite.nnThree engineered changes to the native GLP-1 backbone (an Aib substitution at position 8, a Lys-to-Arg substitution at position 34, and a C18 fatty diacid attached at lysine 26) give semaglutide its long plasma half-life and once-weekly dosing profile
Keep the BAC water ratio consistent across vials so unit math stays predictable
HbA1c, glycated hemoglobin
Together, these studies suggest that BBS disrupts CNS processing of satiety cues, contributing to hyperphagia and obesity
FDA approval of tirzepatide for obstructive sleep apnea in adults with obesity